Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 17 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

GERD-related laryngitis diagnosis differs between specialities

March's issue of the American Journal of Gastroenterology shows that there is a dichotomy in treatment dose, duration, and perceived patient response to therapy between ear, nose, and throat physicians, and gastroenterologists.

News image

fiogf49gjkf04

Ear, nose, and throat physicians often diagnose gastroesophageal reflux disease (GERD)-related laryngitis.

This diagnosis is made on the basis of symptoms and laryngeal signs.

Patients may be referred to gastroenterologists who contend that many such patients do not have reflux.

Dr Tasneem Ahmed and colleagues from Ohio assessed this practice pattern differences among physicians and gastroenterologists.

The research team evaluated the differences in relation to the diagnosis and treatment of patients with GERD-related laryngitis.

Separate surveys were specifically designed for physicians and gastroenterologists.

Many gastroenterologists perform pre-therapy tests with low sensitivity in GERD-related laryngitis
American Journal of Gastroenterology

The surveys assessed the percentage of patients diagnosed with GERD-related laryngitis, as well as dose and duration of therapy.

Treatment response, and other diagnostic options in nonresponders were also assessed.

The team randomly mailed surveys to the American Academy of Otolaryngology Head and Neck Surgery and the American Gastroenterological Association.

Of the total 4,000 surveys sent, 39% of the ear, nose, and throat physicians and 28% of gastroenterologists responded.

The researchers observed that most respondents were private practitioners.

From the ear, nose, and throat survey, the diagnosis was most commonly based on symptoms such as globus, or throat clearing, cough, and hoarseness.

The team found that the most useful signs were laryngeal erythema and edema reported by 70% of respondents.

Of the ear, nose, and throat physicians, 74% reported they made the diagnosis more on symptoms than on laryngeal signs.

These physicians initiated therapy most often with proton pump inhibitor (PPI) once daily for 2 months.

The team noted that gastroenterologists were divided on pre-therapy testing.

About 50% reporting testing with esophagogastro-duodenoscopy followed by pH monitoring prior to therapy.

The researchers observed that the remaining 50% reported treating empirically with PPI twice daily for 3 months.

Of the gastroenterologists, 70% reported treatment response of less than 60%.

However, 62% of ear, nose, and throat physicians reported a response rate of greater than 60%.

Dr Ahmed's team concluded, “Globus and throat clearing were considered the most useful symptoms in diagnosing GERD-related laryngitis for ear, nose, and throat physicians.”

“Laryngeal erythema and edema were considered the most useful signs for diagnosis and treatment of this condition by ear, nose, and throat physicians.”

“However, these symptoms and signs may represent the least specific markers for reflux.”

“Many gastroenterologists perform pre-therapy testing which has low sensitivity in GERD-related laryngitis.”

“There is a dichotomy in treatment dose, duration, and perceived patient response to therapy between the 2 specialists.”

“Our study highlights a need for cross communication and education between these 2 disciplines in understanding and treating GERD-related laryngitis better.”

Am J Gastroenterol 2006: 101(3): 470
14 March 2006

Go to top of page Email this page Email this page to a colleague

 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 20 December 2017 
Management of abnormal liver blood tests
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD
 13 December 2017 
Tryptophan metabolism and IBD activity
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy
 12 December 2017 
High-risk colorectal cancer patients
 06 December 2017 
Reflux-induced chronic cough 
 06 December 2017 
Systemic inflammatory response syndrome in acute-on-chronic liver failure

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us